This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: generic prescribing

September 2007 Br J Cardiol 2007;14:229-33

Generic or intensive statin therapy: saving money or saving lives?

Rob Butler

Abstract

This drive towards generic prescribing for statins for all patients, with reduced efficacy, is against the published data from a large series of randomised-controlled trials and is counterintuitive. Funding organisations are being misinformed if they consider the swapping of effective treatment in this high-risk population is at all benign. This review seeks to demonstrate the strength of data and real-world experience suggesting that intensive statin therapies have real benefits for high-risk patients.  Introduction Dr Rob Butler There has been mounting controversy within a number of healthcare systems due to the expanding indications for s

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now